In the article titled "Effect of High, Medium, and Low Molecular Weight Hyaluronan on Inflammation and Oxidative Stress in an In Vitro Model of Human Nasal Epithelial Cells" \[[@B1]\], there was a duplication of bands and undeclared splicing in the Western Blots. After this was raised on PubPeer, the following concerns were confirmed: [Figure 1(a)](#fig1){ref-type="fig"} *β*-actin lanes 1 and 2 appear to be the same as [Figure 4](#fig4){ref-type="fig"} *β*-actin lanes 1 and 2. They represent the same conditions (untreated cells and rh-IL-17A), but the duplication was not declared. [Figure 1(a)](#fig1){ref-type="fig"} *β*-actin lanes 1-3 are also the same as [Figure 2](#fig2){ref-type="fig"} *β*-actin lanes 1-3, though the latter has been compressed horizontally to about 70% of the width. The third lane is not the same experiment.[Figure 1(a)](#fig1){ref-type="fig"} pERK lanes 1 and 2 are the same as [Figure 3(b)](#fig3){ref-type="fig"} pERK lanes 1 and 2, and they appear to represent the same conditions.[Figure 1(b)](#fig1){ref-type="fig"} *β*-actin lanes 1 and 2 are the same as [Figure 3(b)](#fig3){ref-type="fig"} *β*-actin lanes 1 and 2. [Figure 1(b)](#fig1){ref-type="fig"} pI*κ*B*α* lanes 1 and 2 are the same as [Figure 3(b)](#fig3){ref-type="fig"} pI*κ*B*α* lanes 1 and 2. However, the ratios reported in the respective bar charts above the blots are quite different.[Figure 2(b)](#fig2){ref-type="fig"} *β*-actin lanes 1 and 2 are the same as [Figure 4(b)](#fig4){ref-type="fig"} lanes 1 and 2, though the latter has been compressed horizontally to about 70% of the width.

The authors apologized for the confusion and said this was due to inadvertent human error. They prepared a new set of figures, which have no duplication. A declaration of splicing between the bands is included in the legends of Figures [1(a)](#fig1){ref-type="fig"} and [2(b)](#fig2){ref-type="fig"}. The corrected figures, as approved by the editorial board, are as follows:

Dr. Liboria Siena, the sixth author of the article, sadly passed away in November 2016.
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=======================

###### 

The uncropped gels showing the selected bands for Figures 1(a), 2(b), 3(a), and 4(b).

###### 

Click here for additional data file.

![Effect of the U0126 inhibitor on ERK and I*κ*B*α* phosphorylation in RPMI 2650 cells stimulated with rhIL-17A. The cells were stimulated with rhIL-17A (20 ng/mL) or PMA (50 ng/mL) for 30 min in the absence or presence of U0126 (25 *μ*M). (a) pERK and pI*κ*B*α* protein expressions were evaluated in the cell lysates by western blot. The results were expressed as the ratio of band intensity and *β*-actin of 3 separate experiments. Representative gel images of pERK, pI*κ*B*α*, and *β*-actin are shown. The bands are spliced from uncropped blots. (b) The activation of ERK1/2 and NF-*κ*B for each experimental condition was tested for the pERK1/2/total ERK1/2 ratio and for the pNF-*κ*B/total NF-*κ*B, respectively, by ELISA, and normalized for protein content. ANOVA with Fisher\'s test correction was used for the analysis of the data. *p* \< 0.05 was statistically significant.](MI2019-9198518.001){#fig1}

![Effect of the U0126 inhibitor in RPMI 2650 cells stimulated with rhIL-17A. (a) The cells were stimulated with rhIL-17A (20 ng/mL) for 6 hrs in the absence or presence of U0126 (25 *μ*M). ROS production was evaluated in the cells by flow cytometry. The bars represent the mean ± SD of 3 separate experiments. Representative flow cytometry is shown; (b) the cells were stimulated with rhIL-17A (20 ng/mL) for 18 hrs in the absence or presence of U0126 (25 *μ*M). NOX-4 and IL-8 protein expressions were evaluated in the cell lysates by western blot. The results were expressed as the ratio of band intensity and *β*-actin of 3 separate experiments. Representative western blot is shown. The bands are spliced from uncropped blots. ANOVA with Fisher\'s test correction was used for the analysis of the data. *p* \< 0.05 was statistically significant.](MI2019-9198518.002){#fig2}

![Effect of HMW-HA, MMW-HA, and LMW-HA on ERK1/2 and NF-*κ*B signal pathway in RPMI 2650 cells stimulated with rhIL-17A. The cells were preincubated with HMW-HA (100 *μ*g/mL), MMW-HA (100 *μ*g/mL), and LMW-HA (100 *μ*g/mL) for 1 h and then stimulated with rhIL-17A (20 ng/mL) for 30 min; (a) pERK and pI*κ*B*α* protein expressions were evaluated in the cell lysates by western blot. The bars represent the ratio of band intensity and *β*-actin of 3 separate experiments. Representative gel images of pERK, pI*κ*B*α*, and *β*-actin are shown; (b) the activation of ERK1/2 and NF-*κ*B for each experimental condition was tested for the pERK1/2/total ERK1/2 ratio and pNF-*κ*B/total NF-*κ*B ratio by ELISA and normalized for protein content. ANOVA with Fisher\'s test correction was used for the analysis of the data. *p* \< 0.05 was statistically significant.](MI2019-9198518.003){#fig3}

![Effect of HMW-HA, MMW-HA, and LMW-HA in RPMI 2650 cells stimulated with rhIL-17A. (a) The cells were preincubated with HMW-HA (100 *μ*g/mL), MMW-HA (100 *μ*g/mL), and LMW-HA (100 *μ*g/mL) for 1 h and then stimulated with rhIL-17A (20 ng/mL) for 6 hrs. ROS production was evaluated in the cells by flow cytometry. The bars expressed the mean ± SD of 3 separate experiments. Representative flow cytometry is shown; (b) the cells were preincubated with HMW-HA (100 *μ*g/mL), MMW-HA (100 *μ*g/mL), and LMW-HA (100 *μ*g/mL) for 1 h and then stimulated with rhIL-17A (20 ng/mL) for 18 hrs. NOX-4 and IL-8 protein syntheses were evaluated in the cell lysates by western blot. The bars represent the ratio of band intensity and *β*-actin of 3 separate experiments. Representative western blot is shown. ANOVA with Fisher\'s test correction was used for the analysis of the data. *p* \< 0.05 was statistically significant.](MI2019-9198518.004){#fig4}

![Effect of U0126, HMW-HA, MMW-HA, and LMW-HA on nuclear translocation of NF-*κ*B in RPMI 2650 cells stimulated with rhIL-17A. The cells were preincubated (a) with U0126 (25 *μ*M) or (b) with HMW-HA (100 *μ*g/mL), MMW-HA (100 *μ*g/mL), and LMW-HA (100 *μ*g/mL) for 1 h and then stimulated with rhIL-17A (20 ng/mL) for 30 min; NF-*κ*B was evaluated in nuclear cell lysate by western blot. The bars represent the ratio of band intensity and *β*-actin of 3 separate experiments. Representative gel images of NF-*κ*B and *β*-actin are shown. ANOVA with Fisher\'s test correction was used for the analysis of the data. *p* \< 0.05 was statistically significant.](MI2019-9198518.005){#fig5}
